| 110415-1G |
|
137536-94-8 |
(4R,5R)-2,2-Dimethyl-α,α,α',α'-tetra(1-naphthyl)-1,3-dioxolane-4,5-dimethanol
≥98%,99%e.e.
|
1G |
C47H38O4 |
|
|
|
| 110406-5G |
|
93379-49-8 |
(4S,5S)-2,2-Dimethyl-α,α,α',α'-tetraphenyl-1,3-dioxolane-4,5-dimethanol
≥98%,99%e.e.
|
5G |
C31H30O4 |
|
|
|
| 110406-1G |
|
93379-49-8 |
(4S,5S)-2,2-Dimethyl-α,α,α',α'-tetraphenyl-1,3-dioxolane-4,5-dimethanol
≥98%,99%e.e.
|
1G |
C31H30O4 |
|
|
|
| 110405-5G |
|
93379-48-7 |
(4R,5R)-2,2-Dimethyl-α,α,α',α'-tetraphenyl-1,3-dioxolane-4,5-dimethanol
≥98%,99%e.e.
|
5G |
C31H30O4 |
|
|
|
| 110405-1G |
|
93379-48-7 |
(4R,5R)-2,2-Dimethyl-α,α,α',α'-tetraphenyl-1,3-dioxolane-4,5-dimethanol
≥98%,99%e.e.
|
1G |
C31H30O4 |
|
|
|
| 121426-25G |
|
188264-84-8 |
(1S,2S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
≥98%,-
|
25G |
C36H52CoN2O2 |
|
|
|
| 121426-1G |
|
188264-84-8 |
(1S,2S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
≥98%,-
|
1G |
C36H52CoN2O2 |
|
|
|
| 121415-25G |
|
176763-62-5 |
(1R,2R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
≥98%,-
|
25G |
C36H52CoN2O2 |
|
|
|
| 121415-1G |
|
176763-62-5 |
(1R,2R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
≥98%,-
|
1G |
C36H52CoN2O2 |
|
|
|
| 121406-25G |
|
135616-36-3 |
(1S,2S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine
≥98%,99%e.e.
|
25G |
C36H54N2O2 |
|
|
|
| 121406-1G |
|
135616-36-3 |
(1S,2S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine
≥98%,99%e.e.
|
1G |
C36H54N2O2 |
|
|
|
| 121395-25G |
|
135616-40-9 |
(1R,2R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine
≥95%,99%e.e.
|
25G |
C36H54N2O2 |
|
|
|
| 121395-1G |
|
135616-40-9 |
(1R,2R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine
≥95%,99%e.e.
|
1G |
C36H54N2O2 |
|
|
|
| 200122-100MG |
|
919102-70-8 |
(5aS,?10bR)?-5a,?10b-?Dihydro-?2-?(2,?4,?6-?trimethylphenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Chloride
≥98%,99%e.e.
|
100MG |
C21H22N3O·Cl |
|
|
|
| 137915-100MG |
|
1787246-78-9 |
(5aS,?10bR)?-?2-?(2,?6-Diethylphenyl)?-?5a,?10b-?dihydro-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,-
|
100MG |
C22H24N3O·BF4 |
|
|
|
| 137916-100MG |
|
1221487-76-8 |
(5aR,?10bS)?-?2-?(2,?6-Diethylphenyl)?-?5a,?10b-?dihydro-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C22H24N3O·BF4 |
|
|
|
| 200033-100MG |
|
463326-78-5 |
(5aS,?10bR)?-?5a,?10b-Dihydro-?2-?(4-?methoxyphenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,-
|
100MG |
C19H18N3O2·BF4 |
|
|
|
| 200032-100MG |
|
941283-79-0 |
(5aR,?10bS)?-?5a,?10b-Dihydro-?2-?(4-?methoxyphenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C19H18N3O2·BF4 |
|
|
|
| 136232-250MG |
|
1710476-21-3 |
(S)-5-(Diphenyl((trimethylsilyl)oxy)methyl)-2-mesityl-5,6-dihydro-[1,2,4]triazolo[3,4-a]isoquinolin-2-ium Tetrafluoroborate
≥98%,-
|
250MG |
C35H38N3OSi·BF4 |
|
|
|
| 136232-50MG |
|
1710476-21-3 |
(S)-5-(Diphenyl((trimethylsilyl)oxy)methyl)-2-mesityl-5,6-dihydro-[1,2,4]triazolo[3,4-a]isoquinolin-2-ium Tetrafluoroborate
≥98%,-
|
50MG |
C35H38N3OSi·BF4 |
|
|
|
